Products

Synacthen® Tetracosactide

A diagnostic test for the investigation of adrenocortical insufficiency (Addison’s Disease) (the Test), as well as a short-term therapy in conditions for which glucocorticoids are indicated in principle (e.g. in ulcerative colitis and Crohn's disease, and rheumatoid arthritis) (the Depot).

Formulations: 250mcg/1 ampoules (Test) and 1000mcg/1ml ampoule (Depot)
Territories: Approximately 20 territories globally

Patient information

Healthcare Professional information

Please note

Whilst the Patient Information Leaflets (PIL) and Summary of Product Characteristics (SmPC) product information is intended to be helpful, we stress that this is not intended to, and should not, replace the advice of a qualified medical professional.

If you experience any side effects that cause you concern as a result of the use of any of our products and wish to notify us directly please get in touch via our contact page.

Disclaimer

Please note that the above links are relevant to UK marketing authorisation requirements only. Patients and carers in the Republic of Ireland can find similar information at www.medicines.ie however, if you are from outside the UK, your local country requirements may differ. Please refer to your local country PIL or SPC, if you are a patient or HCP respectively, for further guidance.

Where we have included Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) downloads, we have used the English language versions for the UK (unless otherwise stated). If you would like other language versions for other markets, please contact info@atnahs.com.

Back to all products